NCT04419740 Impact of a Mindfulness Intervention on Infertile Women Undergoing Assisted Reproductive Technique Treatments
| NCT ID | NCT04419740 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Geneva |
| Condition | Infertility, Female |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2021-10-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2021-10-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Infertility and its treatments can have a significant impact on women's psychological health. Anxiety has a negative impact on quality of life during treatment and can lead to withdrawal of care. the investigators would like to test the effectiveness of an application available via the Internet that offers daily exercises such as mindfulness meditation. Women in the "treatment" group will be instructed to practice meditation exercises using the 15-minute daily application during in vitro fertilization treatment until pregnancy testing. Women in the control group will have the standard care of the centre. The investigators will measure the effectiveness of the intervention on anxiety, depression, quality of life and mindfulness aspects. The investigators will also assess the impact on the chances of pregnancy and stress.
Eligibility Criteria
Inclusion Criteria: Participants fulfilling all of the following inclusion criteria are eligible for the study: * French-speaking * Women between the ages of 18-42 years * Scheduled for the first IVF treatment in HUG/CHUV/CPMA Lausanne * Access to a computer/smartphone/tablet with access to internet and a valid Email address * Informed Consent as documented by her signature on the form (Appendix Informed Consent Form) Exclusion Criteria: * Psychotropic medication * Ongoing psychiatric/psychological treatment * Known severe psychiatric co-morbidity
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04419740 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 42 Years, studying Infertility, Female. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04419740 currently recruiting?
Yes, NCT04419740 is actively recruiting participants. Contact the research team at noemie.guedj@hug.ch for enrollment information.
Where is the NCT04419740 trial being conducted?
This trial is being conducted at Geneva, Switzerland.
Who is sponsoring the NCT04419740 clinical trial?
NCT04419740 is sponsored by University Hospital, Geneva. The trial plans to enroll 150 participants.